AAAAAA

   
Results: 1-15 |
Results: 15
ASSOCIATION OF CYTOCHROME-P450 1B1 (CYP1B1) POLYMORPHISM WITH STEROID-RECEPTOR STATUS IN BREAST-CANCER
Authors: BAILEY LR ROODI N DUPONT WD PARL FF
Citation: Lr. Bailey et al., ASSOCIATION OF CYTOCHROME-P450 1B1 (CYP1B1) POLYMORPHISM WITH STEROID-RECEPTOR STATUS IN BREAST-CANCER, Cancer research, 58(22), 1998, pp. 5038-5041
MAPPING OF ER GENE CPG ISLAND METHYLATION BY METHYLATION-SPECIFIC POLYMERASE-CHAIN-REACTION
Authors: LAPIDUS RG NASS SJ BUTASH KA PARL FF WEITZMAN SA GRAFF JG HERMAN JG DAVIDSON NE
Citation: Rg. Lapidus et al., MAPPING OF ER GENE CPG ISLAND METHYLATION BY METHYLATION-SPECIFIC POLYMERASE-CHAIN-REACTION, Cancer research, 58(12), 1998, pp. 2515-2519
BREAST-CANCER AND CYPIA1, GSTM1, AND GSTT1 POLYMORPHISMS - EVIDENCE OF A LACK OF ASSOCIATION IN CAUCASIANS AND AFRICAN-AMERICANS
Authors: BAILEY LR ROODI N VERRIER CS YEE CJ DUPONT WD PARL FF
Citation: Lr. Bailey et al., BREAST-CANCER AND CYPIA1, GSTM1, AND GSTT1 POLYMORPHISMS - EVIDENCE OF A LACK OF ASSOCIATION IN CAUCASIANS AND AFRICAN-AMERICANS, Cancer research, 58(1), 1998, pp. 65-70
HIGH-MOBILITY GROUP (HMG) PROTEIN HMG-1 AND TATA-BINDING PROTEIN-ASSOCIATED FACTOR TAF(II)30 AFFECT ESTROGEN RECEPTOR-MEDIATED TRANSCRIPTIONAL ACTIVATION
Authors: VERRIER CS ROODI N YEE CJ BAILEY LR JENSEN RA BUSTIN M PARL FF
Citation: Cs. Verrier et al., HIGH-MOBILITY GROUP (HMG) PROTEIN HMG-1 AND TATA-BINDING PROTEIN-ASSOCIATED FACTOR TAF(II)30 AFFECT ESTROGEN RECEPTOR-MEDIATED TRANSCRIPTIONAL ACTIVATION, Molecular endocrinology, 11(8), 1997, pp. 1009-1019
IMPACT OF MANAGED CARE ON THE ECONOMICS OF LABORATORY OPERATION IN ANACADEMIC-MEDICAL-CENTER
Authors: BENGE H BODOR GS YOUNGER WA PARL FF
Citation: H. Benge et al., IMPACT OF MANAGED CARE ON THE ECONOMICS OF LABORATORY OPERATION IN ANACADEMIC-MEDICAL-CENTER, Archives of pathology and laboratory medicine, 121(7), 1997, pp. 689-694
METHYLATION OF ESTROGEN AND PROGESTERONE-RECEPTOR GENE 5'-CPG ISLANDSCORRELATES WITH LACK OF ESTROGEN AND PROGESTERONE-RECEPTOR GENE-EXPRESSION IN BREAST-TUMORS
Authors: LAPIDUS RG FERGUSON AT OTTAVIANO YL PARL FF SMITH HS WEITZMAN SA BAYLIN SB ISSA JPJ DAVIDSON NE
Citation: Rg. Lapidus et al., METHYLATION OF ESTROGEN AND PROGESTERONE-RECEPTOR GENE 5'-CPG ISLANDSCORRELATES WITH LACK OF ESTROGEN AND PROGESTERONE-RECEPTOR GENE-EXPRESSION IN BREAST-TUMORS, Clinical cancer research, 2(5), 1996, pp. 805-810
ESTROGEN-RECEPTOR GENE ANALYSIS IN ESTROGEN RECEPTOR-POSITIVE AND RECEPTOR-NEGATIVE PRIMARY BREAST-CANCER
Authors: ROODI N BAILEY LR KAO WY VERRIER CS YEE CJ DUPONT WD PARL FF
Citation: N. Roodi et al., ESTROGEN-RECEPTOR GENE ANALYSIS IN ESTROGEN RECEPTOR-POSITIVE AND RECEPTOR-NEGATIVE PRIMARY BREAST-CANCER, Journal of the National Cancer Institute, 87(6), 1995, pp. 446-451
ANALYSIS OF THE ESTROGEN-RECEPTOR (ER) GENE, TRANSCRIPT AND PROTEIN IN ER-POSITIVE AND ER-NEGATIVE BREAST-CANCER CELL-LINES
Authors: YAICH LE ROODI N BAILEY LR VERRIER CS YEE CJ CAVENER DR PARL FF
Citation: Le. Yaich et al., ANALYSIS OF THE ESTROGEN-RECEPTOR (ER) GENE, TRANSCRIPT AND PROTEIN IN ER-POSITIVE AND ER-NEGATIVE BREAST-CANCER CELL-LINES, Endocrine-related cancer, 2(4), 1995, pp. 293-309
THE INTERACTION OF THE ESTROGEN-RECEPTOR WITH ITS DNA RESPONSE ELEMENT IS FACILITATED BY THE HIGH-MOBILITY GROUP PROTEIN, HMG-1
Authors: VERRIER CS BAILEY LR YEE CJ ROODI N JENSEN RA BUSTIN M PARL FF
Citation: Cs. Verrier et al., THE INTERACTION OF THE ESTROGEN-RECEPTOR WITH ITS DNA RESPONSE ELEMENT IS FACILITATED BY THE HIGH-MOBILITY GROUP PROTEIN, HMG-1, Protein engineering, 8, 1995, pp. 78-78
LONG-TERM RISK OF BREAST-CANCER IN WOMEN WITH FIBROADENOMA
Authors: DUPONT WD PAGE DL PARL FF VNENCAKJONES CL PLUMMER WD RADOS MS SCHUYLER PA
Citation: Wd. Dupont et al., LONG-TERM RISK OF BREAST-CANCER IN WOMEN WITH FIBROADENOMA, The New England journal of medicine, 331(1), 1994, pp. 10-15
P53 GENE MUTATION, PROTEIN EXPRESSION AND PROGNOSIS
Authors: TEAGUE MW CALEFFI M PARL FF VNENCAKJONES CL DUPONT W JENSEN RA
Citation: Mw. Teague et al., P53 GENE MUTATION, PROTEIN EXPRESSION AND PROGNOSIS, Laboratory investigation, 70(1), 1994, pp. 10000023-10000023
MICROSATELLITE INSTABILITY AND LOSS OF HETEROZYGOSITY IN BREAST-CANCER
Authors: YEE CJ ROODI N VERRIER CS PARL FF
Citation: Cj. Yee et al., MICROSATELLITE INSTABILITY AND LOSS OF HETEROZYGOSITY IN BREAST-CANCER, Cancer research, 54(7), 1994, pp. 1641-1644
METHYLATION OF THE ESTROGEN-RECEPTOR GENE CPG ISLAND MARKS LOSS OF ESTROGEN-RECEPTOR EXPRESSION IN HUMAN BREAST-CANCER CELLS
Authors: OTTAVIANO YL ISSA JP PARL FF SMITH HS BAYLIN SB DAVIDSON NE
Citation: Yl. Ottaviano et al., METHYLATION OF THE ESTROGEN-RECEPTOR GENE CPG ISLAND MARKS LOSS OF ESTROGEN-RECEPTOR EXPRESSION IN HUMAN BREAST-CANCER CELLS, Cancer research, 54(10), 1994, pp. 2552-2555
P53 GENE-MUTATIONS AND STEROID-RECEPTOR STATUS IN BREAST-CANCER - CLINICOPATHOLOGICAL CORRELATIONS AND PROGNOSTIC ASSESSMENT
Authors: CALEFFI M TEAGUE MW JENSEN RA VNENCAKJONES CL DUPONT WD PARL FF
Citation: M. Caleffi et al., P53 GENE-MUTATIONS AND STEROID-RECEPTOR STATUS IN BREAST-CANCER - CLINICOPATHOLOGICAL CORRELATIONS AND PROGNOSTIC ASSESSMENT, Cancer, 73(8), 1994, pp. 2147-2156
A 10-YEAR ANALYSIS OF REVENUES, COSTS, STAFFING, AND WORKLOAD IN AN ACADEMIC-MEDICAL-CENTER CLINICAL-CHEMISTRY LABORATORY
Authors: BENGE H CSAKO G PARL FF
Citation: H. Benge et al., A 10-YEAR ANALYSIS OF REVENUES, COSTS, STAFFING, AND WORKLOAD IN AN ACADEMIC-MEDICAL-CENTER CLINICAL-CHEMISTRY LABORATORY, Clinical chemistry, 39(9), 1993, pp. 1780-1787
Risultati: 1-15 |